Ruminococcus

Ruminococcus gnavus is a Gram-positive, anaerobic bacterium naturally found in the human gut microbiome. While it can be part of a healthy intestinal ecosystem, certain strains are considered pathobionts – microbes that are usually harmless but can cause harm under specific conditions.

Ruminococcus gnavus, Inflammation and Arthritis

Recent microbiome research links overgrowth of R. gnavus with inflammatory and autoimmune diseases, including:

  • Ankylosing spondylitis (A.S.)

  • Rheumatoid arthritis (RA)

  • Inflammatory bowel disease (IBD), particularly Crohn’s disease

  • Systemic lupus erythematosus (SLE)


How Does Ruminococcus gnavus Relate to Arthritis?

Several studies have found enrichment of R. gnavus in the gut microbiome of patients with inflammatory arthritis compared to healthy controls.

The suspected mechanisms include:

  1. Mucolytic activity – R. gnavus can degrade the protective mucin layer of the gut, increasing permeability (“leaky gut”), allowing bacterial products like lipopolysaccharides (LPS) or peptidoglycan to cross into the bloodstream and trigger immune activation.

  2. Pro-inflammatory polysaccharides – Certain strains produce unique glucorhamnan polysaccharides that can stimulate TLR4-dependent immune responses, increasing pro-inflammatory cytokines (Henke et al., Cell Host & Microbe, 2019).

  3. Molecular mimicry – Fragments of R. gnavus antigens may resemble host proteins, potentially driving autoimmunity in genetically susceptible individuals.


What Feeds Ruminococcus gnavus?

R. gnavus tends to thrive on:

  • Mucin (from the gut lining) – especially during gut inflammation when mucin production increases.

  • Low-fibre, high-fat diets – associated with reduced diversity and overgrowth of mucin-degraders.

  • Animal-based protein and saturated fat – some studies suggest these favour R. gnavus over beneficial fibre-fermenters.

  • Simple sugars – may indirectly promote conditions where mucin degraders thrive.

  • Antibiotic use – can deplete competing bacteria, allowing R. gnavus to expand.


What Suppresses Ruminococcus gnavus?

Evidence suggests the following can help keep R. gnavus in check:

  • High-fibre diets – especially prebiotic fibres like inulin, resistant starch, and arabinoxylans that feed beneficial butyrate-producers.

  • Polyphenols – from berries, green tea, pomegranate, and cocoa; these can modulate gut microbiota composition.

  • Omega-3 fatty acids – shown to support anti-inflammatory bacterial profiles.

  • Probiotics – particularly Bifidobacterium and Lactobacillus species may help restore mucosal integrity and competitive exclusion.

  • Taurine & zinc synergy – from shellfish such as oysters and mussels; taurine chloramine has anti-inflammatory effects that may indirectly reduce R. gnavus–driven inflammation.

  • Boron compounds – have shown suppression of other inflammatory gut pathogens like Klebsiella in vitro, though specific R. gnavus effects need more research.


Impact on Gut Barrier and Inflammation

  • R. gnavus can break down mucin into monosaccharides, depriving gut epithelium of protection.

  • Overgrowth is associated with reduced butyrate levels, a key short-chain fatty acid that nourishes colon cells and maintains tight junctions.

  • Gut permeability increases systemic exposure to bacterial antigens, which in arthritis-prone individuals may worsen joint inflammation.

Practical Considerations

  • Increase plant diversity: Aim for at least 30 different plant foods per week.

  • Include anti-inflammatory fats: Oily fish, flaxseed, walnuts.

  • Cut refined sugar and saturated animal fats: Helps reduce the conditions favouring mucin degraders.

  • Antibiotics caution: Avoid unnecessary use. Maintain microbial diversity.

  • Support gut lining repair: Nutrients like glutamine, zinc, omega-3, and polyphenols may help.

References

  1. Henke, M.T., Kenny, D.J., Cassilly, C.D., Vlamakis, H., Xavier, R.J., & Clardy, J. (2019). Ruminococcus gnavus, a member of the human gut microbiome associated with Crohn’s disease, produces an inflammatory polysaccharide. Cell Host & Microbe, 25(5), 677–688.

  2. Hall, A.B., Tolonen, A.C., & Xavier, R.J. (2017). Human genetic variation and the gut microbiome in disease. Nature Reviews Genetics, 18(11), 690–699.

  3. Chen, L., Wilson, J.E., Koenigsknecht, M.J., et al. (2017). Niche and nutrient competition drive Ruminococcus gnavus expansion in inflammatory bowel disease. Nature Microbiology, 2, 16249.

  4. Lopetuso, L.R., Scaldaferri, F., Petito, V., & Gasbarrini, A. (2013). Commensal clostridia: Leading players in the maintenance of gut homeostasis. Gut Pathogens, 5, 23.